Synthorx Inc. announced the appointment of Marcos Milla, Ph.D. as senior vice president of research. Dr. Milla's expertise in drug discovery spans across the areas of autoimmunity and inflammation, neurosciences and pain, and immuno-oncology. He has held industry and academic appointments at GlaxoSmithKline, Perelman School of Medicine at the University of Pennsylvania, Roche Palo Alto, Janssen Research & Development, and, most recently, Adaptive Biotechnologies. He has previously directed efforts focusing on multiple intracellular and extracellular target classes, including cell surface and nuclear receptors, ion channels, kinases and proteinases.